학술논문
SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST)
Document Type
Journal
Author
Jerusalem, Guy; Farah, Subrina; Chirgwin, Jacquie; Aebi, Stefan; Karlsson, Per; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavila, Joaquin; Kuroi, Katsumasa; Marth, Christian; Mueller, Bettina; O'Reilly, Seamus; Gombos, Andrea; Ruhstaller, Thomas; Burstein, Harold; Rabaglio, Manuela; Ruepp, Barbara; Viale, Giuseppe; Gelber, Richard D.; Coates, Alan S.; Di Leo, Angelo; Goldhirsch, Aron; Regan, Meredith; Colleoni, Marco
Source
Subject
Language
English
ISSN
15387445